Le Lézard
Classified in: Health
Subject: SVY

The Global Advanced Ultrasound Imaging Systems Market is forescasted to grow at a CAGR of 8.39% during the period 2018-2022


LONDON, Oct. 16, 2018 /PRNewswire/ -- About Advanced Ultrasound Imaging Systems

An ultrasound scan is a medical test that uses high-frequency sound waves to capture live images of internal body parts. The procedure is also known as sonography. Advanced ultrasound imaging provides images that are three-dimensional (3D) or higher.

Download the full report: https://www.reportbuyer.com/product/5589826

Technavio's analysts forecast the Global Advanced Ultrasound Imaging Systems Market to grow at a CAGR of 8.39% during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the advanced ultrasound imaging systems market. To calculate the market size, the report considers the revenue generated from the retail sales of advanced ultrasound imaging systems across the globe.

The market is divided into the following segments based on geography:
? Americas
? APAC
? EMEA

Technavio's report, advanced ultrasound imaging systems market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
? Canon Medical Systems
? GE Healthcare
? Samsung Healthcare
? Siemens Healthcare
? Koninklijke Philips

Market driver
? Recent advances in ultrasound technology
? For a full, detailed list, view our report

Market challenge
? High cost of advanced ultrasound imaging systems
? For a full, detailed list, view our report

Market trend
? Rise in M&A activities
? For a full, detailed list, view our report

Key questions answered in this report
? What will the market size be in 2022 and what will the growth rate be?
? What are the key market trends?
? What is driving this market?
? What are the challenges to market growth?
? Who are the key vendors in this market space?
? What are the market opportunities and threats faced by the key vendors?
? What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Download the full report: https://www.reportbuyer.com/product/5589826

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +1 (718) 213 4904
Website: www.reportbuyer.com

SOURCE ReportBuyer


These press releases may also interest you

at 13:26
In a bid to foster excellence and innovation in the healthcare industry, the esteemed Dr. Vidal Sheen proudly announces the launch of The Dr. Vidal Sheen Grant for Healthcare Students. With a robust focus on academic prowess, compassionate care, and...

at 13:17
Rexall is proud to unveil its first Pharmacist Care Walk-In Clinic in Barrie, Ontario on Friday, April 19. Located at 353 Duckworth Street, the clinic will offer personalized care to the community while providing immediate pharmacist treatment for...

at 13:13
Caring for communities extends beyond life-changing work in operating rooms and physician offices. Hartford HealthCare leadership today highlighted its corporate responsibility to environmental, social and economic sustainability in announcing its...

at 13:04
Concept Medical, a pioneer in innovative drug delivery technologies, proudly announces the commencement of its groundbreaking IDE clinical study, "MAGICAL-ISR" using MagicTouch ? Sirolimus drug coated balloon (DCB), for the management of in-stent...

at 12:30
The American College of Physicians (ACP) today released an update of its 2017 guideline with clinical recommendations for the use of newer pharmacological treatments of adults with Type 2 diabetes. The clinical guideline is based on the best...

at 12:10
Pieris Pharmaceuticals, Inc. today announced that its Board of Directors has approved a 1-for-80 reverse stock split of the Company's common stock, par value $0.001, which will be effective at 5:00 pm Eastern Time on April 22, 2024. The Company's...



News published on and distributed by: